IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $248,000 | -86.6% | 50,000 | -79.9% | 0.01% | -80.6% |
Q4 2021 | $1,850,000 | -4.9% | 249,283 | -27.3% | 0.07% | +13.6% |
Q3 2021 | $1,945,000 | -57.2% | 343,048 | -50.2% | 0.06% | -58.2% |
Q2 2021 | $4,541,000 | -30.3% | 689,049 | -14.3% | 0.14% | -24.2% |
Q1 2021 | $6,514,000 | +64.1% | 804,192 | +30.7% | 0.19% | +29.2% |
Q4 2020 | $3,969,000 | +179.1% | 615,286 | +17.3% | 0.14% | -28.7% |
Q1 2019 | $1,422,000 | -39.9% | 524,600 | +6.3% | 0.20% | -57.3% |
Q4 2018 | $2,368,000 | +25.0% | 493,400 | +146.7% | 0.47% | +18.8% |
Q3 2018 | $1,894,000 | – | 200,000 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |